Liquidity & Technical

Liquidity & Technical

A 5% portfolio position in Zoetis is implementable in five trading days at 20% of ADV for funds up to roughly $13.6 billion in AUM, so liquidity is not the bottleneck — the tape is. Price sits 37.9% below the 200-day moving average with realized volatility at a 5-year high of 77%; the dominant tape feature is the May 7 distribution event that broke the multi-year support shelf on 6.8x average volume.

Price snapshot

Price action — 10-year picture vs 50/200-day moving averages

Price is below the 200-day moving average by 37.9%. This is a downtrend, not a sideways consolidation. The stock peaked at $247.05 in late-2021, broke long-term trend in 2024, and accelerated lower in the May 2026 distribution event. The 200-day SMA has been rolling over since mid-2024 — both price and trend slope point down.

Relative price trajectory — 3-year rebased

Across 5-year, 3-year, 1-year and YTD windows, total return is negative (−53.2%, −56.9%, −51.3%, −36.7% respectively). The gap to any reasonable equity benchmark has widened, not narrowed; this is a sustained relative-strength loss, not a single-window air pocket.

Momentum — RSI and MACD

RSI fell to 11.7 on May 13 — a multi-year extreme oversold — and has bounced to 25.3. That is a textbook capitulation-and-bounce signature; it does not imply a trend change, only that one-way selling pressure has eased. MACD line remains deeply negative at −11.1 with the histogram improving from −4.2 to −1.5 over the last two weeks — momentum is bottoming, not reversing. Near-term (1–3 month) read: tradable bounce off oversold; no MACD bullish crossover yet to confirm a momentum turn.

Volume, distribution days, and volatility regime

The May 7 event is the dominant fingerprint on this chart: 28.9M shares (~6.8x average) on a −21.5% close, followed by a −5.1% session on 17.2M shares the next day. That is institutional distribution, not retail panic — the size cleared because real holders were exiting. The 50-day average volume has roughly doubled since early May, which mechanically widens future ADV (helpful for exits) but is itself a stress signal.

Realized vol jumped from ~25% (normal band) to 77% in two weeks — that is a 5-year high and well above the p80 stress threshold of 28.8%. The market is demanding a much wider risk premium to hold ZTS; option-implied vols will follow. Until realized vol normalizes back toward the 20–30% band, position sizing should assume a stressed regime, not the pre-event base case.

Institutional liquidity panel

This section answers a single question: can the stock absorb real institutional size? Yes, comfortably — and the recent volume surge has made it easier, not harder, to enter or exit.

ADV and turnover

20-day ADV has risen sharply versus 60-day (8.5M vs 5.3M shares) because the May distribution event tripled daily turnover. Annual turnover at 239% means the entire float changes hands roughly every five months — far above the typical large-cap healthcare baseline of 80–120%.

Fund capacity by ADV participation and position weight

A 5% portfolio weight clears five trading days at 20% ADV for funds up to ~$13.6B AUM (or ~$6.8B at the more conservative 10% ADV cap). A 2% weight scales to ~$34B/$17B respectively. ZTS supports almost any size institutional manager outside the very largest mega-funds without becoming the market.

Liquidation runway

Median daily range over the last 60 sessions is 1.24% — below the 2% threshold that flags elevated impact cost. Intraday execution friction is low even with the recent volatility spike, because spreads on an S&P 500 large-cap stay tight even when volatility widens.

Largest size that clears 5 trading days at 20% ADV: 1.0% of market cap (~$354M). At the more conservative 10% ADV cap: 0.5% (~$177M). Liquidity is not the constraint on this name.

Technical scorecard + stance

Aggregate technical score: −5 of −6 (bearish).

Stance — 3-to-6 month horizon: bearish, with a defined bounce-trade window

The weight of evidence is bearish: price below all major moving averages, an active death cross, a stressed-vol regime, and institutional distribution two weeks ago. The single offset is the RSI bottoming pattern, which supports a tactical bounce attempt but does not change the trend.

Two levels define the next move:

• Above $109.50 (50-day SMA): a sustained reclaim of the 50-day on rising volume would be the first piece of evidence that the regime is changing. Until then, rallies should be sold or used to reduce exposure.
• Below $74.20 (52-week low): a clean break extends the capitulation; next reference is the 2020 COVID-era support shelf in the $60s.

Liquidity is not the constraint — it is sentiment and the absence of a fundamental catalyst to reverse the trend. The correct posture for a long-biased fund is: watchlist only at current levels; build slowly over multiple weeks (not days) if and when the stock reclaims the 50-day SMA and realized vol falls back below 40%. For a fund already long, the May 7–12 distribution should be read as institutional handover; trimming into any rally toward $95–100 is defensible while a $74 break is risked.